Advertisement

Intramyocardial Ejection of Basic Fibroblast Growth Factor Increased Regional Myocardial Blood Flow Andsalvaged Infarcted Myocardium in Dogs

  • Masaru Miyataka
  • Kinji Ishikawa
  • Iwao Ogawa
  • Hironari Koka
  • Shoji Nakai
  • Hirofumi Kino
  • Masahiko Inagaki
  • Akio Kimura
  • Takaya Hasegawa
  • Koji Kitayama
  • Ryo Katori
Part of the Progress in Experimental Cardiology book series (PREC, volume 1)

Abstract

We studied whether basic fibroblast growth factor (bFGF) might increase regional Myocardial blood flow (Qm) at the infarcted myocardium. In eight dogs, bFGF 300 μg was injected into the myocardium supplied by the left anterior descending coronary artery (LAD), and the artery was ligated. In 12 dogs, saline was injected (control group). Nonradioactive colored microspheres were used to determine Qm. The amount of viable myocardium and the extent of fibrosis in the infarcted area four weeks after occlusion were measured histologically. In the outer layer, the Qm values immediately after and four weeks after occlusion were 26 ± 2% and 70 ± 6%, respectively, in the control group, and 46 ± 5% and 121 ± 13%, respectively, in the bFGF group. The Qm at both times in the bFGF group was significantly higher than the corresponding control group values (p < 0.01). The Qm at four weeks in the inner and middle layers also significantly increased in the bFGF group. There was more viable myocardium (control vs. bFGF group: 41 ± 5% vs. 61 ± 7%, p < 0.05) and less fibrosis (3.1 ± 0.2 vs. 2.0 ± 0.4, p < 0.01) at the outer layer in the bFGF group. bFGF caused a marked increase of the Qm, an increase of viable myocardium, and a decrease of fibrosis at the infarcted myocardium. We conclude bFGF was effective in limiting infarct size in acute myocardial infarction.

Keywords

Infarct Size Left Anterior Descendng Myocardial Blood Flow Basic Fibroblast Growth Factor Viable Myocardium 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Yanagisawa-Miwa A, Uchida Y, Nakamura F, Tomaru T, Kido H, Kamijo T, Sugimoto T, Kaji K, Utsuyama M, Kurashima C, Ito H. 1992. Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor. Science 257:1401–1403.PubMedCrossRefGoogle Scholar
  2. 2.
    Unger EF, Banai S, Shou M, Lazarous DF, Jaklitsch MT, Scheinowitz M, Correa R, Klingbeil C, Epstein SE. 1994. Basic fibroblast growth factor enhances myocardial collateral flow in a canine model. Am J Physiol 266:H1588–H1595.PubMedGoogle Scholar
  3. 3.
    Lopez JJ, Starebier A, Edelman ER, Hibberd MG, Caputo RP, Carrozza JP, Prasad PV, Douglas PS, Sellke FW, Simons M. 1995. Local bFGF treatment results in angiographic collateral development, dose related increase in coronary flow and myocardial function in chronic myocardial ischemia (abstract). Circulation 92:1–67.Google Scholar
  4. 4.
    Lazarous DF, Scheinowitz M, Shou M, Hodge E, Rajanayagam MAS, Hunsberger S, Robison WG Jr, Stiber JA, Correa R, Epstein SE, Unger EF. 1995. Effects of chronic systemic administration of basic fibroblast growth factor on collateral development in the canine heart. Circulation 91:145–153.PubMedGoogle Scholar
  5. 5.
    Ishikawa K, Kamata N, Nakai S, Akiyama H, Koka H, Ogawa I, Katori R. 1994. Preservation of high regional blood flow at epicardial rim after coronary occlusion in dogs. Am J Physiol 267:H528–H534.PubMedGoogle Scholar
  6. 6.
    Uchida Y, Yanagisawa-Miwa A, Nakamura F, Yamada K, Tomaru T, Kimura K, Morita T. 1995. Angiogenic therapy of acute myocardial infarction by intrapericardial injection of basic fibroblast growth factor and heparin sulfate: An experimental study. Am Heart J 130:1182–1188.PubMedCrossRefGoogle Scholar
  7. 7.
    Unger EF, Banai S, Shou M, Jaklitsch MT, Epstein SE. 1991. Intracoronary injection of basic fibroblast growth factor enhances collateral blood flow in the canine myocardium (abstract). Circulation 84:II–96.Google Scholar
  8. 8.
    Miyataka M, Ishikawa K, Ogawa I, Koka H, Nakai S, Kino H, Inagaki M, Kimura A, Katori R. 1996. Contralateral arterial bolus injection of 30 micrograms of basic fibroblast growth factor failed to augment myocardial blood flow in infarcted myocardium in dogs. Acta Med Kinki Univ 21:53–58.Google Scholar
  9. 9.
    Battler A, Scheinowitz M, Bor A, Hasdai D, Vered Z, Di Segni E, Varda-Bloom N, Nass D, Engelberg S, Eldar M, Belkin M, Savion N. 1993. Intracoronary injection of basic fibroblast growth factor enhances angiogenesis in infarcted swine myocardium. J Am Coll Cardiol 22:2001–2006.PubMedCrossRefGoogle Scholar
  10. 10.
    Harada K, Grossman W, Friedman M, Edelman ER, Prasad PV, Keighley CS, Manning WJ, Sellke FW, Simons M. 1994. Basic fibroblast growth factor improves myocardial function in chronically ischemic porcine hearts. J Clin Invest 94:623–630.PubMedCrossRefGoogle Scholar
  11. 11.
    Sellke FW, Wang SY, Friedman M, Harada K, Edelman ER, Grossman W, Simons M. 1994. Basic FGF enhances endothelium-dependent relaxation of the collateral-perfused coronary microcirculation. Am J Physiol 267:H1303–H1311.PubMedGoogle Scholar
  12. 12.
    Landau C, Jacobs AK, Haudenschild CC. 1995. Intrapericardial basic fibroblast growth factor induces myocardial angiogenesis in a rabbit model of chronic ischemia. Am Heart J 129:924–931.PubMedCrossRefGoogle Scholar
  13. 13.
    Inagaki M, Ishikawa K, Ogawa I, Koka H, Nakai S, Kino H, Kimura A, Myataka M, Katori R. 1996. Regional blood flow in infarcted myocardium of basic fibroblast growth factor-treated rats. Acta Med Kinki Univ 21:59–63.Google Scholar
  14. 14.
    Banai S, Jaklitsch MT, Casscells W, Shou M, Shrivastav S, Correa R, Epstein SE, Unger EF. 1991. Effects of acidic fibroblast growth factor on normal and ischemic myocardium. Circ Res 69:76–85.PubMedGoogle Scholar
  15. 15.
    Edelman ER, Nugent MA, Karnovsky MJ. 1993. Perivascular and intravenous administration of basic fibroblast growth factor: Vascular and solid organ deposition. Proc Natl Acad Sci USA 90:1513–1517.PubMedCrossRefGoogle Scholar
  16. 16.
    Reimer KA, Lowe JE, Rasmussen MM, Jennings RB. 1977. The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs. Circulation 56:786–793.PubMedGoogle Scholar
  17. 17.
    Kostyk SK, Kourembanas S, Wheeler EL, Medeiros D, McQuillan LP, D’Amore PA, Braunhut SJ. 1995. Basic fibroblast growth factor increases nitric oxide synthase production in bovine endothelial cells. Am J Physiol 269:H1583–H1589.PubMedGoogle Scholar
  18. 18.
    Casscells W. 1995. Growth factor therapies for vascular injury and ischemia. Circulation 91:2699–2702.PubMedGoogle Scholar

Copyright information

© Kluwer Academic Publishers 1998

Authors and Affiliations

  • Masaru Miyataka
    • 1
  • Kinji Ishikawa
    • 1
  • Iwao Ogawa
    • 1
  • Hironari Koka
    • 1
  • Shoji Nakai
    • 1
  • Hirofumi Kino
    • 1
  • Masahiko Inagaki
    • 1
  • Akio Kimura
    • 1
  • Takaya Hasegawa
    • 1
  • Koji Kitayama
    • 1
  • Ryo Katori
    • 1
  1. 1.Kinki University School of MedicineJapan

Personalised recommendations